Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Alk-Abello ASCHIX:ALKBC 92 Intrinsic Value: Projected FCF is kr61.94 as of Sep. 16, 2026. GuruFocus rates CHIX:ALKBC with a GF Score™ of 92/100 and a GF Value™ of kr227.77 (Fairly Valued). Among 257 Biotechnology companies, Alk-Abello AS ranks worse than 65.76% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
As of today (2026-09-16), Alk-Abello AS's Intrinsic Value: Projected FCF is kr61.94. The stock price of Alk-Abello AS is kr221.50. Therefore, Alk-Abello AS's Price-to-Intrinsic-Value-Projected-FCF of today is 3.6.
The historical rank and industry rank for Alk-Abello AS's Intrinsic Value: Projected FCF or its related term are showing as below:
CHIX:ALKBc'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 3.13 Med: 8.08 Max: 18.4
Current: 3.58
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Alk-Abello AS was 18.40. The lowest was 3.13. And the median was 8.08.
CHIX:ALKBc's Price-to-Projected-FCF is ranked worse than 65.76% of 257
companies
in the Biotechnology industry
Industry Median: 2.09
vs CHIX:ALKBc: 3.58
Alk-Abello AS (CHIX:ALKBc) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Alk-Abello AS's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
221.50
/
70.64420652263
=
3.14
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alk-Abello AS Intrinsic Value: Projected FCF Related Terms
Alk-Abello AS Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Alk-Abello AS's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alk-Abello AS Intrinsic Value: Projected FCF Chart
CHIX:ALKBC vs VRTX, REGN, MRNA: Intrinsic Value: Projected FCF Comparison
For the Biotechnology subindustry, Alk-Abello AS's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alk-Abello AS Price-to-Projected-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Alk-Abello AS's Price-to-Projected-FCF falls into.
Alk-Abello AS Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of kr61.94 mean?
Alk-Abello AS (CHIX:ALKBC) has a Intrinsic Value: Projected FCF of kr61.94 as of Sep. 16, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Alk-Abello AS and its competitors. According to the industry distribution chart, Alk-Abello AS ranks #169 out of 257 companies in the Biotechnology industry, placing it in the top 65.8%.
Is Alk-Abello AS's Intrinsic Value: Projected FCF too high?
Alk-Abello AS's current Intrinsic Value: Projected FCF is kr61.94. Based on the distribution chart, Alk-Abello AS ranks #169 out of 257 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Alk-Abello AS has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Intrinsic Value: Projected FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alk-Abello AS ranks #169 out of 257 companies for Intrinsic Value: Projected FCF. This places Alk-Abello AS in the lower half of its industry. The industry median Intrinsic Value: Projected FCF is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Biotechnology company?
The median Intrinsic Value: Projected FCF among Biotechnology companies is 2.09, based on 257 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Alk-Abello AS and its competitors. For the Biotechnology industry, the median Intrinsic Value: Projected FCF is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alk-Abello AS's current Intrinsic Value: Projected FCF is kr61.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (CHIX:ALKBC) is currently considered Fairly Valued. The stock's GF Value™ is kr227.77, compared to a current price of kr221.50 — trading 2.8% below its estimated fair value. The current Intrinsic Value: Projected FCF is kr61.94. Alk-Abello AS's overall GF Score™ is 92/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Alk-Abello AS (CHIX:ALKBC), the current Intrinsic Value: Projected FCF is kr61.94 as of Sep. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alk-Abello AS (CHIX:ALKBC) Overvalued in 2026?
Based on GuruFocus' analysis, Alk-Abello AS stock appears to be undervalued.
The current stock price of kr221.50 is trading 2.8% below its estimated GF Value™ of kr227.77.
GuruFocus considers Alk-Abello AS to be Fairly Valued.
Key valuation signals for CHIX:ALKBC:
Intrinsic Value: Projected FCF: kr61.94
GF Value™: kr227.77 vs. price of kr221.50 (2.8% below fair value)
No single metric tells the full story. See the CHIX:ALKBC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
92GF Score
Get the complete analysis for CHIX:ALKBC
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:ALKBC has been successfully added to your 
